My Best Radial Case of the Past Year ... And what I learned from it

Slides:



Advertisements
Similar presentations
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
Advertisements

Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
New York City Direct Referral to Catheterization Lab STEMI Notification & Transportation Protocol.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
on behalf of the TOTAL Investigators
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
Masoudi FA et al J Am Coll Cardiol (Published online 27 November 2008) CVN Weekly Interventional Update December 8, 2008 Jeffrey J. Popma and Christopher.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
Sunil V. Rao MD The Duke Clinical Research Institute The Durham VA Medical Center Duke University Medical Center Transradial PCI in Octogenarians: Caveats,
Presentation at a Non PCI Facility Requiring Transfer Does NOT Worsen Long-term Prognosis in Patients With STEMI Undergoing Primary Angioplasty. The HORIZONS-AMI.
Hypothermia in awake STEMI patients:
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Left Ventricular Twist Mechanics in Heart Failure: Evolving Role in the Assessment of Cardiac Dyssynchrony M Bertini, PP Sengupta, G Nucifora, V Delgado,
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
Disclosure Statement of Financial Interest
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Balloon-pump assisted Coronary Intervention Study BCIS-1 Simon Redwood Divaka Perera, Rod Stables, Martyn Thomas.
Messy Inferior STEMI J. Jeffrey Marshall, MD, FSCAI December 8, 2012.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Recent Advances in Cardiopulmonary Resuscitation:
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Treatment Times Through Formalized.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Transradial Best Practices for Radial Access
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Simplifying Serial Lesion Assessment
Interesting-Didactic Cases
Nightmares in the Cath Lab
Risk Stratification of Chest Pain: Best Practices
Pros and Cons of Radial Access
CART-CL: Clinical and Research Update
Coronary stent immobilisation with rapid ventricular pacing technique via coronary guidewire in non-ST elevation myocardial infarction Dr Zaid Iskandar.
Challenging Case Presentations From South Texas Methodist Hospital
Should We Preload STEMI Patients with Antiplatelet Therapy?
Clinical Presentation
PCI related in-hospital mortality based on race and gender in the USA
Tarek Abou Ghazala, MD, FACC, FSCAI
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
The TREAT Study: Can Devices Lower Bleeding Rates?
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Kirk N Garratt MSc MD FSCAI
Complex PCI to CTO lesion in RCA with nightmares complications
Transradial Intervention as Access of Choice in STEMI
Radial vs Femoral Access in ACS Patients
Sunil V. Rao MD The Duke Clinical Research Center
Fractional Flow Reserve Workshop
Cath Lab Catastrophes : Prevention & Management Strategies
It’s Elementary.
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Heart Failure Prevention: Mission Impossible?
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
The HORIZONS-AMI Trial
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
What oral antiplatelet therapy would you choose?
OHSU Chest Pain Program
Maintenance of Long-Term Clinical Benefit with
Infarct Size after Primary Angioplasty Patients With Bivalirudin
European Heart Journal Advance Access
The impact of registries on clinical practice in the united states
Hypothermia in awake STEMI patients:
Presentation transcript:

My Best Radial Case of the Past Year ... And what I learned from it CRT 2017 February 20, 2017

Disclosures Consulting: Research Grants: Terumo Interventional Systems Boston Scientific Medtronic Acist Medical Research Grants: Edwards LifeSciences Abbott

Case Presentation 67 year old male No significant PMH Called EMS with chest pain of 1 hour duration Cardiac arrest essentially as EMS arrived ACLS per protocol Initial rhythm VF Shocked with ROSC Intubated in field ECG with inferior ST-elevation Field activated STEMI Taken straight to Cath Lab on arrival Hemodynamically stable, Killip Class 2 Modified Allen’s Normal – yes, we still check

STEMI - Prep

6F Access – IL 3.5 Guide System connected from beginning 0.035” J-wire left in guide catheter Pulled back a few inches for left coronary system I still prefer contralateral first approach

6F Access – IL 3.5 Guide Advance J-wire almost to guide tip for RCA Will leave in place until 0.014” wire down Convert passive support to active support

Standard STEMI Management

STEMI – Primary PCI

Inferior STEMI (field activated) Times: Symptoms to EMS – 60 minutes EMS to Door – 32 minutes Door to Cath Lab – 5 minutes Cath lab to Access time – 9 minutes Access to Device time – 12 minutes Metrics: Door to Device time – 24 minutes EMS to Device time – 56 minutes

Post Cath Course Taken to CVICU upon case completion Targeted Temperature Management Post STEMI care No residual defects Discharged on hospital day # 5. Seen in clinic for follow-up …

Why this case . . . Was this really my “best case”??? No. Transradial STEMI is routine in our lab. The RCA was straightforward. It’s a good result, but nothing special Was this my best ”learning experience” In full disclosure: I’ve been totally schooled over the past year. I tend to remember and learn from negatives.

We can Learn from Positives as well This is access, not religion. Bleeding reduction is a good thing. Coaxial guide engagement is what matters. We are here to treat patients. Excepts from past conferences.

RIFLE STEACS 30-day MACE rate p = 0.02 p = 1.00 p = 0.6 p = 0.73 Romagnoli et al. J Am Coll Cardiol 2012 60 2481 13

RIFLE STEACS 30-day NACE predictors OR CI 95% p value Female gender 1.5 (1.1-2.3) 0.037 CKD 2.1 (1.4-3.1) 0.001 Radial access 0.6 (0.4-0.9) 0.012 Killip class 1.8 (1.5-2.2) LAD culprit 1.7 (1.2-2.6) 0.006 TIMI 0 basal 1.4 (1.0-2.1) 0.073 LVEF <50% 1.6 (1.1-2.5) 0.025 TIMI 0-1 final 2.4 (1.1-5.1) 0.024 p= 0.002 Romagnoli et al. J Am Coll Cardiol 2012 60 2481

NCDR CathPCI Registry Access Trends STEMI 2007-2011 (n=90,879) Baklanov et al. J Am Coll Cardiol. 2013 61 420

NCDR CathPCI Registry STEMI 2007-2011 (n=90,879) Baklanov et al. J Am Coll Cardiol. 2013 61 420

Conclusions We can learn from all experiences Positive and negative The work that we do really does translate back to the patient

Thank You